The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1326
ISSUE1326
November 30, 2009
Aliskiren/Valsartan (Valturna) for Hypertension
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Aliskiren/Valsartan (Valturna) for Hypertension
November 30, 2009 (Issue: 1326)
The FDA has approved the use of aliskiren (Tekturna), a direct renin inhibitor, with valsartan (Diovan), an angiotensin-receptor blocker (ARB), in a fixed-dose combination as Valturna (Novartis) for treatment of hypertension in patients already...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.